What Actually Happens When Medications Expire — And When It Matters

couple looking at computer asking questions

What Actually Happens When Medications Expire

And When It Matters

By Cayla McGrath

If you’ve ever stood in front of your medicine cabinet holding a bottle a year past the printed date, wondering whether to toss it or keep it, you already know there are exactly two kinds of advice available: “probably fine, just use it” and “throw it out immediately, it might be toxic.” Neither one is fully right, and neither one is actually useful.

The honest answer is more specific — and more practical — than either extreme. Some medications are nearly as stable at two years past their date as they were the day they shipped. Others become unreliable faster, and a small number have real limitations. Knowing which category you’re dealing with changes what you do.

The expiration date is a guarantee, not a cliff

The date on a medication bottle is a manufacturer’s commitment: the drug holds at least 90% of its labeled potency under the specified storage conditions up to that date. It doesn’t say anything about a sudden drop the day after. The decline past it is gradual and varies significantly by drug.

The best evidence on how long that decline really takes comes from the FDA and Department of Defense Shelf Life Extension Program (SLEP), which stability-tests federal stockpiles and extends dating when products still pass. Across 2,650 of 3,005 lots tested, spanning 122 products, about 88% remained stable for an average of 66 months past their labeled date. None failed within the first year past dating.

Here’s the piece that almost every article leaves out: that stockpile sat in climate-controlled federal warehouses. Not in a bathroom cabinet above a hot shower. Heat and humidity are the real drivers of pharmaceutical degradation, and the SLEP data tells us the label is conservative — it doesn’t tell us your specific bottle, in your specific storage environment, is still at full potency five years out.

Three categories that tell you what you actually need to know

Not all medications degrade the same way, and lumping them together is what produces both the careless responses and the unnecessary panic.

Oral tablets and capsules — ibuprofen, acetaminophen, most antibiotics in pill form — are the most stable. The SLEP data is clearest here: ciprofloxacin tablets held 100% potency across 242 lots tested; ceftriaxone powder held 100%. Stored in a cool, dry location away from the bathroom, well-formulated tablets degrade slowly and predictably. The failure mode, when it eventually comes, is a weaker drug — not a dangerous one.

Liquids, suspensions, and reconstituted medications are less stable. An amoxicillin suspension mixed with water starts degrading immediately and is typically reliable for 10 to 14 days refrigerated. Liquid antibiotics, eye drops, and oral suspensions should generally not be treated as long-term stockpile items.

Medications with narrow therapeutic windows warrant more caution simply because even modest potency reduction becomes clinically relevant. This category also includes refrigeration-dependent medications: insulin stored improperly becomes unreliable, which is a different kind of problem when you’re managing a condition that depends on it.

The famous toxic expired drug story

If you’ve heard that expired medications can become toxic, the story traces back to a case from 1963: tetracycline capsules that degraded into a compound linked to kidney damage. That case became the foundation of decades of “expired medications are dangerous” warnings.

The tetracycline formulation that caused that problem no longer exists. The anhydrous form manufactured since the early 1970s does not produce the same degradation product. The concern was real in the 1960s, and it’s been irrelevant since. The story outlived the problem by about sixty years.

That doesn’t mean you should ignore expiration dates. It means you should be skeptical of any source that uses that story to justify blanket “throw everything out” advice without acknowledging that the underlying chemistry changed.

What this means for preparedness

If you’re building any kind of medication supply, storage conditions are the variable that matters most. The bathroom medicine cabinet is one of the worst environments in your home: high humidity, temperature fluctuations from showers. A cool, dry closet shelf is significantly better. An airtight container is better still.

What to replace first: liquid suspensions (especially if mixed), medications stored in heat or humidity, refrigeration-dependent items that may have been temperature-excursioned, and anything with visible physical changes — discoloration, odor, clumping.

What you don’t need to panic-replace: well-stored tablets and capsules a year or two past their label date. The SLEP data doesn’t make them immortal, but it gives you a meaningful margin when storage conditions are right.

At Jase, we send every kit with guidance on storage conditions because this is the variable most people overlook. A JaseCase stored properly and replaced on a reasonable schedule gives you what you actually need when you need it.

Learn more at jase.com/

Cayla McGrath is a content strategist with Jase Medical. This post is for informational purposes only and does not constitute medical advice. Always consult a licensed healthcare provider before using any prescription medication.

Lifesaving Solutions

Everyone should be empowered to care for themselves and their loved ones during the unexpected. Check out our recent lifesaving products today.

Learn More

Join Our Newsletter

Our mission is to help you be more medically prepared. Join our newsletter and follow us on social media for health and safety tips each week!

For Clinicians | Do Expired Medications Still Work?

Guide to What to Keep, Replace, and Never Trust in an Emergency

By Dr. Jamie Wilkey, PharmD — Director of Clinical Strategy, Jase
Medically reviewed by Kristen Carpenter, PA-C — Clinical Advisory Board Member

“Is this still good?” A patient holds up a bottle a year or two past the dispense date.

Most of us answer with some version of a shrug: probably fine, maybe just toss it.

Neither “you’re fine” nor “throw it all out” is the 100% right answer for every medication. Here is the three-tier map of what actually happens to a drug after its date, plus the one famous “toxic expired drug” story that hasn’t been true in sixty years.

Do expired medications still work?

Mostly yes, with important exceptions. The expiration date is a manufacturer’s guarantee, not a cliff. It certifies the drug holds at least 90% of its labeled potency under specified storage conditions up to that date.¹ It says nothing about a sudden drop the day after, and the decline past it is gradual and drug-dependent.

The best data we have on how long that decline really takes comes from the FDA and Department of Defense Shelf Life Extension Program, which stability-tests federally stockpiled medications and extends their dating when they still pass. Across the published readout, 2,650 of 3,005 lots, about 88 percent, spanning 122 products stayed stable for an average of 66 months, roughly five and a half years, past their labeled date, and none failed within the first year.² That is the number that gets quoted everywhere, and it is where almost every article stops. The part they leave out is the part that matters most for the patient standing in their bathroom: that stock sat in climate-controlled federal warehouses, not a cabinet above a hot shower.³ Heat and humidity accelerate degradation, so the bottle in a steamy bathroom does not get five and a half years. The SLEP data tells us the date is conservative. It does not tell us your patient’s ibuprofen is guaranteed effective until 2031.

Which expired medications are actually risky?

This is where the single exception list every other article publishes falls apart. “Expired” hides three very different situations, and lumping them together is what leaves patients either careless about the dangerous ones or panicked about the harmless ones.

Here is how we sort them:

Tier 1, loses potency slowly, low harm. Most solid oral tablets and capsules: ibuprofen, acetaminophen, most antibiotics in tablet form. The SLEP data lands hardest here. Ciprofloxacin tablets held 100 percent potency across 242 lots; ceftriaxone powder held 100 percent.⁴ Stored dry and cool, these degrade slowly and predictably, and the failure mode is a weaker drug, not a toxic one. A two-years-past ibuprofen from a kitchen drawer is very probably still doing something. Tell the patient it may be a little weaker, not that it will hurt them.

Tier 2, fails silently when you need it most. Nitroglycerin, epinephrine and EpiPens, insulin, rescue inhalers, naloxone. This is the tier that actually earns fear, and it is the one patients most often get wrong by keeping an expired one “just in case.” The risk here is not poisoning. It is a critical drug quietly underperforming in the exact moment that demands full potency, the chest pain, the anaphylaxis, the overdose. Nitroglycerin degrades fast and unpredictably once the bottle is opened; epinephrine and insulin lose potency with heat and time without changing how they look. One thing worth telling patients over and over again: for this tier, an expired dose is not a backup. Replace these on schedule, and do not let an out-of-date one stand in for the real thing in an emergency.

Tier 3, genuinely degrades or destabilizes. Liquid antibiotic suspensions, biologics, vaccines, and some eye drops. Here the problem is the formulation itself coming apart: reconstituted suspensions separate and lose dosing accuracy, biologics and vaccines are sensitive to time and temperature, and eye drops carry a sterility clock that has nothing to do with potency. These are replace-on-expiry, and for ophthalmics the open-bottle date often matters more than the printed one.

For Tier 1 the real cost of expiry is lost potency, not toxicity.
The drugs that deserve genuine caution are the ones in Tier 2 and Tier 3, and almost none of that caution is about poison.

Doesn’t expired tetracycline cause Fanconi syndrome?

This is the one every clinician half-remembers, and it is worth getting right because it is the only “expired drugs are toxic” claim with any clinical history behind it. The story is real but old. In 1963, Frimpter and colleagues reported three patients who developed Fanconi syndrome, a form of proximal renal tubule damage, after taking degraded tetracycline, with one further report following in 1981.⁵ The culprits were specific degradation products, anhydrotetracycline and epi-anhydrotetracycline, formed in old formulations of the drug.

What gets lost is everything since. The 2024 review of expired-antibiotic efficacy states it plainly: no recent cases of toxicity from expired oral tetracycline or its derivatives, including doxycycline, have been reported.⁶ A handful of cases from the early 1960s, tied to formulations that are not what sits on the shelf today, became a permanent line in patient-facing articles that name doxycycline as dangerous-when-expired with no historical context at all. The accurate version is both more interesting and more reassuring: there is no documented modern case of expired doxycycline causing Fanconi syndrome. When a patient raises it, you can correct it cleanly instead of repeating it.

What this means for medical preparation

The takeaway is not “expired drugs are fine” or “throw everything out on the date.” It is that the date means different things for different drugs, and a household that keeps medications on hand should know which tier each one sits in. That is the whole point of appropriate medical preparation: not stockpiling for its own sake, but holding the right things, stored the right way, and knowing what each one is actually good for when the moment comes. A drawer of expired ibuprofen is a minor footnote. An expired EpiPen someone is counting on is a real problem.

This is the kind of grey area we think clinicians should be charting out loud, instead of leaving patients to sort it from a search result. Working through a medicine cabinet tier by tier is genuinely time-consuming, so here is the rule of thumb worth handing a patient: if it is a solid pill or capsule kept somewhere cool and dry, the printed date is a guideline, and it is very likely still working a year or two past it. If it is something you would reach for in an emergency, nitroglycerin, an EpiPen, insulin, an inhaler, naloxone, or anything liquid, reconstituted, or refrigerated, treat the date as a deadline and replace it on schedule. Storage beats the calendar either way: a drug kept out of the bathroom and away from heat outlasts the same one stored over a hot shower. And when a specific drug really matters, the dispensing pharmacist is the best free reference there is. A quick call to the office or the pharmacy settles most of these.

None of this replaces primary care. The chronic conditions, the complex diagnoses, the ongoing relationship belong in the exam room. But preparation is something we care about deeply at Jase, and the medicine cabinet is exactly where it tends to go sideways. People hold onto medications and either assume they are good forever or churn through them far more often than they need to, when the truth sits in between and depends entirely on the drug. We love helping people keep what they need on hand in a way that will actually work the moment they reach for it.

TL;DR

The expiration date is a conservative guarantee, not a cliff, and for most solid pills stored well it is genuinely cautious. But “expired” is not one thing. A weaker ibuprofen and a quietly dead EpiPen read the same on the label and could not be more different in the moment that counts. Sort by tier, not by date: don’t panic over the tablets, replace the rescue drugs and the refrigerated and liquid ones on schedule, and retire the sixty-year-old fear that expired doxycycline will poison anyone. The date tells you when the manufacturer’s promise ends. It does not tell you what the drug can still do, and knowing the difference is the part worth being good at.

Sources

Expiration date = ≥90% labeled potency guarantee, not a cliff
Pharmacy Times, Help Patients Understand Drug Expiration Dates
https://www.pharmacytimes.com/view/help-patients-understand-drug-expiration-dates
SLEP headline: 2,650 of 3,005 lots (~88%), 122 products, avg 66 months past label, none failed in year one
Lyon et al. 2006, Stability Profiles of Drug Products Extended beyond Labeled Expiration Dates, J Pharm Sci 95(7), as compiled in the 2024 PMC review
https://pmc.ncbi.nlm.nih.gov/articles/PMC11117793/
SLEP stock sat in climate-controlled federal warehouses, not a home cabinet
FDA, Expiration Dating Extension
https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/expiration-dating-extension
Ciprofloxacin tablets 100% across 242 lots; ceftriaxone powder 100%
2024 PMC review citing the SLEP drug-class breakdown
https://pmc.ncbi.nlm.nih.gov/articles/PMC11117793/
1963 Frimpter et al., three Fanconi cases (plus a 1981 report); culprits anhydrotetracycline and epi-anhydrotetracycline
Frimpter GW et al., Reversible “Fanconi Syndrome” Caused by Degraded Tetracycline, JAMA. 1963;184:111-113; Montoliu et al. 1981
https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/570490
“No recent cases of toxicity… doxycycline” from expired tetracyclines
2024 PMC review, Efficacy of Expired Antibiotics: A Real Debate in the Context of Repeated Drug Shortages
https://pmc.ncbi.nlm.nih.gov/articles/PMC11117793/

Lifesaving Solutions

Everyone should be empowered to care for themselves and their loved ones during the unexpected. Check out our recent lifesaving products today.

Learn More

Join Our Newsletter

Our mission is to help you be more medically prepared. Join our newsletter and follow us on social media for health and safety tips each week!

Why You Can’t Count on the Pharmacy in a Crisis

By Aaron Asay, PA-C, DMSc — Executive Director, JaseResponse

Most of the time, the pharmacy works exactly the way we expect it to.

Your child develops strep throat, the pediatrician sends in amoxicillin, and you pick it up on your way home. You’ve taken the same blood pressure medication for years, and each month your refill is waiting for you. A specialist adjusts a medication, and within a day or two it’s available through your local pharmacy.

Until suddenly, it isn’t.

Maybe it’s October and your child needs amoxicillin suspension, but the pharmacist tells you they don’t have any in stock. Maybe the medication you’ve taken successfully for years is suddenly backordered, and the substitute offered feels unfamiliar. Maybe a family member receives a call from their infusion center explaining that their treatment has been placed “on allocation” and that no one can confidently say when a stable supply will return.

These moments feel frustrating because we’ve grown accustomed to assuming medications will always be available when we need them. But increasingly, these aren’t unusual weeks in healthcare. They are becoming part of the environment patients, pharmacists, and prescribers are practicing inside.

I’ve spent years responding to disasters, humanitarian crises, and disruptions where access to healthcare suddenly changed overnight. During these deployments, I’ve witnessed families struggling to obtain medications they depend on simply because roads were impassable, pharmacies were closed, or healthcare systems were overwhelmed.

What’s been striking over the past several years is recognizing that families no longer need a hurricane, wildfire, or flood to experience similar disruptions. Sometimes, all it takes is a manufacturing issue halfway around the world, a shortage of active pharmaceutical ingredients, transportation bottlenecks, or increased demand for a commonly prescribed medication.

The Healthcare System Itself Has Begun Acknowledging This Reality

In a recent survey published in JAMA Network Open, nearly 90% of primary care physicians reported experiencing drug shortages within the previous six months. Almost half reported watching a patient’s disease progress while trying to navigate workarounds, and more than one in ten reported a major adverse event related to medication shortages.

This doesn’t mean families should panic or begin stockpiling medications.

It does mean we may need to rethink what preparedness looks like.

At Jase, our family team of medical doctors, physician assistants, and pharmacists has spent years working in the space between traditional primary care and the moments when traditional access breaks down. We often describe this as appropriate medical preparation.

For many families, appropriate medical preparation has two practical layers:

The first layer is continuity. It’s maintaining a documented supply of the medications your family already depends on whenever possible. It means keeping a written medication list that includes drug names, dosages, prescribing providers, and pharmacies. It means having enough margin that an unexpected backorder, shipping delay, or shortage doesn’t immediately become a crisis.

Second Layer

The second layer involves contingency planning. Certain conditions repeatedly emerge during disruptions, whether they’re caused by disasters, shortages, or healthcare access challenges. Having contingency antibiotics and emergency medications available, accompanied by clinician-reviewed guidance about when to use them and when to seek additional care, can help families navigate those situations more confidently.

Importantly, none of this replaces a relationship with a primary care physician.

Primary Care Foundation

Primary care remains the foundation of good healthcare. Chronic conditions, ongoing management decisions, preventive care, and new diagnoses belong in the exam room. Appropriate medical preparation simply acknowledges that healthcare increasingly operates within a system that isn’t always predictable. It offers patients and clinicians a thoughtfully built second layer so that the phone call from the pharmacy doesn’t become the only plan a family has.

Resilience

After years of disaster response, one lesson has become increasingly clear to me: resilience isn’t built in the middle of a crisis. It’s built beforehand, through small decisions that create stability when systems become strained.

For some families, that may simply mean asking their provider about extending a maintenance medication supply. For others, it may mean building a more comprehensive preparedness plan. The goal isn’t fear. The goal isn’t stockpiling. The goal is having enough margin that when the routine channel temporarily stops working, your family still has options.

Because whether the disruption comes from a hurricane, a wildfire, a global manufacturing issue, or a medication shortage no one saw coming, preparation creates capacity.

Capacity to stay calm. Capacity to adapt. Capacity to have compassion for others in crisis.

And ultimately, capacity to care for the people around us while the system catches up.At Jase, that’s what we believe appropriate medical preparation looks like

Lifesaving Solutions

Everyone should be empowered to care for themselves and their loved ones during the unexpected. Check out our recent lifesaving products today.

Learn More

Join Our Newsletter

Our mission is to help you be more medically prepared. Join our newsletter and follow us on social media for health and safety tips each week!

For Clinicians | Drug Shortages 2026

Prescribing Inside a Supply Chain the System Has Admitted Isn’t Built for Disruption

By Dr. Jamie Wilkey, PharmD — Director of Clinical Strategy, Jase
Medically reviewed by Kristen Carpenter, PA-C — Clinical Advisory Board Member

A Dad comes to the counter an hour before the pharmacy closes for the night and asks why his daughter’s strep Rx isn’t ready yet.

“Sorry, sir, that antibiotic for your child isn’t something we have in stock right now so I can’t fill the prescription for you tonight since I don’t have anything on hand I can easily switch it to.”

“Ah. That’s so frustrating!!!! You’ll get it in tomorrow, right?!”

That’s the question I’ve answered more times than I can count, standing behind a pharmacy counter on a holiday weekend, looking at a parent trying to fill a script for liquid amoxicillin or azithromycin for a kid who is miserable. The shelves behind me look full. They are. They just don’t have what this family needs. The wholesaler order will show up on Monday or Tuesday…. but I won’t know what’s actually in it until I open the tote and see what ABC or Cardinal sent me. Until then, all I can tell her is, “I don’t have it now, and I hope to get it on Monday.” She can’t bank on that either. She knows it.

The next options aren’t great. The pharmacy across town might have it, but her insurance isn’t accepted there, or it’s already closed for the weekend, or it has shorter holiday hours and will be closed before she can get there, or it means setting up a new profile and re-entering all her billing info just for this one prescription. That’s a big old pain. And the kid feels worse by the hour.

This isn’t a one-off year. It feels monthly. And when there’s no substitute formulation on the shelf, the call goes back to the prescriber for a new drug at a different dose. On a Saturday night, both of us trying to track each other down in time to actually get the kid treated.

Today we’re talking about drug shortages in 2026: what ASPE/HHS now says on the record about a supply chain that isn’t built for disruption, and what a stable practice posture looks like when you’re prescribing inside it.

How bad are drug shortages in 2026, really?

Worse than we realize, and lasting longer than the system has trained us to expect.

Three-quarters of the drug shortages currently active in the US began in 2022 or later¹. The median active shortage now runs 2.55 years across all drugs, and 4.60 years for sterile injectables². This isn’t a temporary interruption you and your patient ride out. It’s a sustained structural condition we’re prescribing inside.

The supply side explains the durability. As of August 2024, only 24% of the API manufacturing facilities producing drugs for the US market sat inside the United States, down from 28% in August 2019³. Most of what we hand a patient is made upstream of a global chain we don’t control, and the chain isn’t getting more local.

In its September 2025 report on supply chain resilience, ASPE/HHS reviewed the methods that exist for measuring whether the medical supply chain is actually prepared, and concluded that “few have been widely adopted or proven scalable across product types or supply chain segments”⁴. HHS doesn’t yet have widely-adopted tools for measuring its own resilience. We’re prescribing inside it anyway.

What’s actively short in summer 2026

In Q1 2026, ASHP counted 223 active national drug shortages, the second consecutive quarter the count has risen⁵. The mix isn’t the headlines you might remember.

ADHD stimulants: amphetamine mixed salts (IR and XR), lisdexamfetamine, and methylphenidate ER are in their fourth year of active shortage. Specific strengths of amphetamine XR had release dates as recently as mid-May and early-June 2026.

Sterile injectable chemotherapy: vinblastine, methotrexate, and cisplatin are all currently short. Vinblastine is the most-shorted oncology drug, reported in shortage at 57% of surveyed centers⁶.

Injectable opioids: morphine sulfate (on the FDA shortage list since 2017) and fentanyl citrate (since 2012) remain chronically short. Acute pain, surgical anesthesia, palliative care.

Estradiol and progesterone: added to the shortage list in January and February 2026. Demand is up; manufacturing capacity hasn’t caught up.

88% of PCPs hit a shortage in the past six months

Pharmacy school, medical school, PA school: all of us trained inside a system where medication stock was reasonably predictable. That system isn’t real life these days. What replaced it is a fragmented, partly-imported, partly-allocated, partly-rationed pipeline that none of us were taught to prescribe inside. The training assumed reliability. The job no longer offers it.

And the data has caught up to what we already knew. In a JAMA Network Open survey published January 7, 2026, 88% of primary care physicians (795 of 902 surveyed) reported experiencing a drug shortage in the prior six months. Eighty-seven percent of those PCPs reported quality-of-care changes tied directly to the shortage. Forty-nine percent watched a patient’s disease progress while they were trying to find a workaround. Thirteen percent had a patient hit a major adverse event7. That isn’t a hypothetical risk profile. That’s the clinical environment we’re working in right now.

The 2022-2023 amoxicillin shortage is the clean case. After the FDA shortage declaration, the odds of a pediatric acute otitis media patient being prescribed amoxicillin dropped by 91%. Amoxicillin-clavulanate and cefdinir prescriptions rose 7-fold and 9-fold8. The shortage didn’t just delay care; it shifted the entire prescribing pattern for the most common pediatric bacterial infection toward broader-spectrum, second-line antibiotics. The stewardship cost of that shift is real, and nobody planned for it.

This is what practicing inside a structurally unreliable supply chain looks like, right now.

What stable practice posture looks like in 2026

Stable practice posture inside this environment has three concrete components. Together they hold when the routine channel doesn’t.

Chronic supply, patient-held: the patient holds an extended physical supply of their actual maintenance medications, with a written list they and any covering provider can read. Ninety days, where insurance allows. Longer where it doesn’t, by self-pay or workaround. The point is the patient has the medication in hand before the routine channel breaks, not after.

Contingency layer: for shortage-prone categories like antibiotics and emergency medications, the patient holds a prescribed supply with clear guidance on when to use it. The clinical work happens on the front end. The patient isn’t winging it on their own at 11pm.

Documentation and decision criteria: what the patient has, what triggers its use, when to defer back to primary care. The framework is written down. Any provider can read it in thirty seconds.

This is what Jase has been building carefully for more than 5 years: appropriate medical preparation. It complements primary care; it does not replace it. The second layer is there for the gap, not the relationship.

Charting the grey area in public

Appropriate medical preparation is a new clinical category, and we’re building it carefully. Documented criteria, not vibes. If a patient is asking you what to have at home just in case and the conversation is going to take longer than you have, you can refer them to us at Jase.com. We’ll do the clinical work in front, document it, and route them back to you for everything else.

Going forward, we’ll share how we make those calls: what we prescribe and why, where the evidence is solid, and where it’s still being written. Public knowledge gets better when clinicians chart the grey area in public, not when we leave the internet to do it.

The team is family medicine physicians, physician assistants, and pharmacists with field experience in disaster medicine and humanitarian response. The clinical work happens on the front end, so the patient isn’t winging it on their own at 11pm.

Sources

ASHP National Drug Shortages Report, Q4 2025. Released January 2026. https://www.ashp.org/drug-shortages/shortage-resources/drug-shortages-statistics
ASPE/HHS Office of Science and Data Policy. Analysis of Drug Shortages, 2018-2023 (Data Brief). January 10, 2025. https://aspe.hhs.gov/reports/drug-shortages-data-brief
ASPE/HHS Office of Science and Data Policy. Analysis of Drug Shortages, 2018-2023 (Data Brief). January 10, 2025. The 28% (August 2019) baseline references Janet Woodcock, FDA testimony, “Safeguarding Pharmaceutical Supply Chains in a Global Economy,” October 30, 2019. https://aspe.hhs.gov/reports/drug-shortages-data-brief
ASPE/HHS (Mathematica). Defining and Measuring the Resilience, Criticality, and Vulnerability of Medical Product Supply Chains. September 2025. https://aspe.hhs.gov/reports/measuring-supply-chain-resilience
ASHP Drug Shortage Statistics. Current National Shortages list, Q1 2026. Cross-referenced with the FDA Drug Shortages Database. https://www.ashp.org/drug-shortages/current-shortages and https://www.fda.gov/drugs/drug-safety-and-availability/drug-shortages
JCO Oncology Practice. National survey on the impact of cancer drug shortages on US oncology practices, 2025. doi:10.1200/OP-25-00381. https://ascopubs.org/doi/10.1200/OP-25-00381
Jarrett JB, Dillane KE, Hollett G, et al. Treatment Modifications After Drug Shortages Among Primary Care Physicians. JAMA Network Open. January 7, 2026. doi:10.1001/jamanetworkopen.2025.52802. https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2843516
Brewster RC, Khazanchi R, Butler A, O’Meara D, Bagchi D, Michelson KA. The 2022 to 2023 Amoxicillin Shortage and Acute Otitis Media Treatment. Pediatrics. September 2023;152(3):e2023062482. doi:10.1542/peds.2023-062482. https://pmc.ncbi.nlm.nih.gov/articles/PMC10895544/

Lifesaving Solutions

Everyone should be empowered to care for themselves and their loved ones during the unexpected. Check out our recent lifesaving products today.

Learn More

Join Our Newsletter

Our mission is to help you be more medically prepared. Join our newsletter and follow us on social media for health and safety tips each week!

What Actually Happens When Medications Expire

And When It Matters

The expiration date is a guarantee, not a cliff

Three categories that tell you what you actually need to know

The famous toxic expired drug story

What this means for preparedness

Lifesaving Solutions

Recent Posts

Join Our Newsletter

For Clinicians | Do Expired Medications Still Work?

Guide to What to Keep, Replace, and Never Trust in an Emergency

Do expired medications still work?

Which expired medications are actually risky?

Doesn’t expired tetracycline cause Fanconi syndrome?

What this means for medical preparation

TL;DR

Sources

Lifesaving Solutions

Recent Posts

Join Our Newsletter

Why You Can’t Count on the Pharmacy in a Crisis

The Healthcare System Itself Has Begun Acknowledging This Reality

Second Layer

Primary Care Foundation

Resilience

Lifesaving Solutions

Recent Posts

Join Our Newsletter

For Clinicians | Drug Shortages 2026

Prescribing Inside a Supply Chain the System Has Admitted Isn’t Built for Disruption

How bad are drug shortages in 2026, really?

What’s actively short in summer 2026

88% of PCPs hit a shortage in the past six months

What stable practice posture looks like in 2026

Charting the grey area in public

Sources

Lifesaving Solutions

Recent Posts

Join Our Newsletter

Recent Posts